Aplenzin (BuPROPion)

Generic Name

BuPROPion

Brand Names

Aplenzin, Auvelity, Forfivo, Wellbutrin

FDA approval date: November 15, 1996

Classification: Aminoketone

Form: Tablet, Kit

What is Aplenzin (BuPROPion)?

APLENZIN is an aminoketone antidepressant, indicated for the treatment of major depressive disorder and seasonal affective disorder . Periodically reevaluate long-term usefulness for the individual patient.

Approved To Treat

Top Global Experts

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Related Clinical Trials

A Phase 1, First-in-human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VX-433 and Its Effects on the Pharmacokinetics of Midazolam and Bupropion

Enrollment Status: Recruiting

Publish Date: June 08, 2026

Intervention Type: Drug

Study Phase: Phase 1

Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-433 following single and multiple ascending doses, as well as to assess the effect of VX-433 on the PK of midazolam, bupropion, and hydroxybupropion.

A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease

Enrollment Status: Recruiting

Publish Date: June 08, 2026

Intervention Type: Drug

Study Phase: Phase 1

Summary: This study is being conducted to understand changes in brain activity following administration of two different drugs (Psilocybin and Dextromethorphan) in older adults with low well-being. The main questions it aims to answer are, does psilocybin: 1. Acutely increase complexity of EEG activity in older adults with low well-being, as modulated by the presence of biomarkers of Alzheimer's disease (A...

Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

Enrollment Status: Recruiting

Publish Date: June 04, 2026

Intervention Type: Drug, Dietary supplement

Study Phase: Early Phase 1

Summary: The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.

View All Clinical Trials